National Scientific Corp. (NSCT) Financials Nov 14
Post# of 250675
Posted On: 11/17/2014 4:26:13 AM
National Scientific Corp. (NSCT) Financials Nov 14, 2014, 4:00 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for National Scientific Corp.
Fiscal year is October-September. All values USD millions. 2007 2009 2010 2012 2013 5-year trend
Sales/Revenue 624,793 358,746 58,788 487,703 516,868
Cost of Goods Sold (COGS) incl. D&A 317,606 180,199 25,595 181,739 243,470
COGS excluding D&A 317,191 179,992 25,595 1,724 0
Depreciation & Amortization Expense 415 207 0 180,015 243,470
Depreciation 415 207 0 0 0
Amortization of Intangibles 0 0 0 180,015 243,470
Gross Income 307,187 178,547 33,193 305,964 273,398
2007 2009 2010 2012 2013 5-year trend
SG&A Expense 440,990 454,594 44,088 374,211 923,161
Research & Development 169,960 110,813 0 151,000 208,895
Other SG&A 271,030 343,781 44,088 223,211 714,266
Other Operating Expense 166,134 0 0 0 0
Unusual Expense 0 0 (8,907) 4,000 6,000
EBIT after Unusual Expense 0 0 8,907 (4,000) (6,000)
Non Operating Income/Expense 25,740 0 0 0 1,353
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 171,525 86,447 5,077 1,488 392
Gross Interest Expense 171,525 86,447 5,077 1,488 392
Interest Capitalized 0 0 0 0 0
Pretax Income (445,722) (362,494) (7,065) (73,735) (654,802)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (445,722) (362,494) (7,065) (73,735) (654,802)
Minority Interest Expense 0 0 0 0 0
Net Income (445,722) (362,494) (7,065) (73,735) (654,802)
Extraordinaries & Discontinued Operations 0 0 0 392,614 23,628
Extra Items & Gain/Loss Sale Of Assets 0 0 - 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 392,614 23,628
Net Income After Extraordinaries (445,722) (362,494) (7,065) 318,879 (631,174)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (445,722) (362,494) (7,065) (73,735) (654,802)
EPS (Basic) () 0.00 0.00 0.00 ()
Basic Shares Outstanding 107.78M 165.28M 165.28M 210.46M 212.8M
EPS (Diluted) () 0.00 0.00 0.00 ()
Diluted Shares Outstanding 107.78M 165.28M 165.28M 210.46M 212.8M
EBITDA (299,522) (275,840) (10,895) 111,768 (406,293)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for National Scientific Corp.
Fiscal year is October-September. All values USD millions. 2007 2009 2010 2012 2013 5-year trend
Sales/Revenue 624,793 358,746 58,788 487,703 516,868
Cost of Goods Sold (COGS) incl. D&A 317,606 180,199 25,595 181,739 243,470
COGS excluding D&A 317,191 179,992 25,595 1,724 0
Depreciation & Amortization Expense 415 207 0 180,015 243,470
Depreciation 415 207 0 0 0
Amortization of Intangibles 0 0 0 180,015 243,470
Gross Income 307,187 178,547 33,193 305,964 273,398
2007 2009 2010 2012 2013 5-year trend
SG&A Expense 440,990 454,594 44,088 374,211 923,161
Research & Development 169,960 110,813 0 151,000 208,895
Other SG&A 271,030 343,781 44,088 223,211 714,266
Other Operating Expense 166,134 0 0 0 0
Unusual Expense 0 0 (8,907) 4,000 6,000
EBIT after Unusual Expense 0 0 8,907 (4,000) (6,000)
Non Operating Income/Expense 25,740 0 0 0 1,353
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 171,525 86,447 5,077 1,488 392
Gross Interest Expense 171,525 86,447 5,077 1,488 392
Interest Capitalized 0 0 0 0 0
Pretax Income (445,722) (362,494) (7,065) (73,735) (654,802)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (445,722) (362,494) (7,065) (73,735) (654,802)
Minority Interest Expense 0 0 0 0 0
Net Income (445,722) (362,494) (7,065) (73,735) (654,802)
Extraordinaries & Discontinued Operations 0 0 0 392,614 23,628
Extra Items & Gain/Loss Sale Of Assets 0 0 - 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 392,614 23,628
Net Income After Extraordinaries (445,722) (362,494) (7,065) 318,879 (631,174)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (445,722) (362,494) (7,065) (73,735) (654,802)
EPS (Basic) () 0.00 0.00 0.00 ()
Basic Shares Outstanding 107.78M 165.28M 165.28M 210.46M 212.8M
EPS (Diluted) () 0.00 0.00 0.00 ()
Diluted Shares Outstanding 107.78M 165.28M 165.28M 210.46M 212.8M
EBITDA (299,522) (275,840) (10,895) 111,768 (406,293)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)